[SLN] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
31-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 25.86%
YoY- -32.80%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 2,099 2,798 9,104 11,374 4,765 3,371 3,643 -30.68%
PBT -14,966 -10,661 -12,010 -12,673 -15,050 -9,326 -13,420 7.51%
Tax -554 -2,411 -1,609 -2,469 -1,287 -2,223 -1,481 -47.99%
NP -14,412 -8,250 -10,401 -10,204 -13,763 -7,103 -11,939 13.33%
Tax Rate - - - - - - - -
Total Cost 16,511 11,048 19,505 21,578 18,528 10,474 15,582 3.92%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -686.61 -294.85 -114.25 -89.71 -288.84 -210.71 -327.72 63.51%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.37 -0.22 -0.29 -0.28 -0.43 -0.22 -0.40 -5.05%
EPS Diluted -0.37 -0.22 -0.29 -0.28 -0.43 -0.22 -0.40 -5.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.